Clinical Trial Update: A NIS Registry of the Prospective Structured Care In Acute Coronary Syndrome

View source ↗

Summary

AstraZeneca-sponsored NIS registry study on prospective structured care in acute coronary syndrome; status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Status: COMPLETED